CID 441871
Scilliroside
Structural Information
- Molecular Formula
- C32H44O12
- SMILES
- CC(=O)O[C@@H]1C[C@@]2([C@H](CC[C@]3([C@@]2(CC[C@@H]3C4=COC(=O)C=C4)O)C)[C@@]5(C1=C[C@H](CC5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O
- InChI
- InChI=1S/C32H44O12/c1-16(34)42-21-13-31(39)23(8-10-30(3)19(7-11-32(30,31)40)17-4-5-24(35)41-15-17)29(2)9-6-18(12-20(21)29)43-28-27(38)26(37)25(36)22(14-33)44-28/h4-5,12,15,18-19,21-23,25-28,33,36-40H,6-11,13-14H2,1-3H3/t18-,19+,21+,22+,23+,25+,26-,27+,28+,29-,30+,31-,32+/m0/s1
- InChIKey
- LSMIOFMZNVEEBR-ICLSSMQGSA-N
- Compound name
- [(3S,6R,8S,9R,10R,13R,14R,17R)-8,14-dihydroxy-10,13-dimethyl-17-(6-oxopyran-3-yl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,6,7,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-yl] acetate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 621.29054 | 233.7 |
[M+Na]+ | 643.27248 | 237.8 |
[M+NH4]+ | 638.31708 | 240.7 |
[M+K]+ | 659.24642 | 241.3 |
[M-H]- | 619.27598 | 235.8 |
[M+Na-2H]- | 641.25793 | 249.3 |
[M]+ | 620.28271 | 234.8 |
[M]- | 620.28381 | 234.8 |